Mouse Genetics Suggests Cell-Context Dependency for Myc-Regulated Metabolic Enzymes during Tumorigenesis

作者: Lisa M. Nilsson , Tacha Zi Plym Forshell , Sara Rimpi , Christiane Kreutzer , Walter Pretsch

DOI: 10.1371/JOURNAL.PGEN.1002573

关键词:

摘要: c-Myc (hereafter called Myc) belongs to a family of transcription factors that regulates cell growth, proliferation, and differentiation. Myc initiates the large cast genes involved in growth by stimulating metabolism protein synthesis. Some these, like those glycolysis, may be part Warburg effect, which is defined as increased glucose uptake lactate production presence adequate oxygen supply. In this study, we have taken mouse-genetics approach challenge role select Myc-regulated metabolic enzymes tumorigenesis vivo. By breeding λ-Myc transgenic mice, Apc(Min) p53 knockout mice with mouse models carrying inactivating alleles Lactate dehydrogenase A (Ldha), 3-Phosphoglycerate (Phgdh) Serine hydroxymethyltransferase 1 (Shmt1), obtained offspring were monitored for tumor development. Very surprisingly, found these are dispensable genetic settings. However, experiments fibroblasts colon carcinoma cells expressing oncogenic Ras show sensitive Ldha knockdown. Our reveal context dependency remarkable ability adapt alterations critical pathways. Thus, achieve clinical success, it will importance correctly stratify patients find synthetic lethal combinations inhibitors targeting enzymes.

参考文章(62)
Jagruti H. Patel, Andrey P. Loboda, Michael K. Showe, Louise C. Showe, Steven B. McMahon, Analysis of genomic targets reveals complex functions of MYC Nature Reviews Cancer. ,vol. 4, pp. 562- 568 ,(2004) , 10.1038/NRC1393
Ronald A. Lubet, Gary Kelloff, Ernest T. Hawk, Kendra Tutsch, Carolyn E. Cole, Russell F. Jacoby, Michael A. Newton, Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryos. Cancer Research. ,vol. 60, pp. 1864- 1870 ,(2000)
Younes ACHOURI, Mark H. RIDER, Emile VAN SCHAFTINGEN, Mariette ROBBI, Cloning, sequencing and expression of rat liver 3-phosphoglycerate dehydrogenase. Biochemical Journal. ,vol. 323, pp. 365- 370 ,(1997) , 10.1042/BJ3230365
X H Zhong, B D Howard, Phosphotyrosine-containing lactate dehydrogenase is restricted to the nuclei of PC12 pheochromocytoma cells. Molecular and Cellular Biology. ,vol. 10, pp. 770- 776 ,(1990) , 10.1128/MCB.10.2.770
Fionnuala Morrish, Nicola Neretti, John M. Sedivy, David M. Hockenbery, The oncogene c-Myc coordinates regulation of metabolic networks to enable rapid cell cycle entry Cell Cycle. ,vol. 7, pp. 1054- 1066 ,(2008) , 10.4161/CC.7.8.5739
Stella Pelengaris, Trevor Littlewood, Michael Khan, George Elia, Gerard Evan, Reversible activation of c-Myc in skin: induction of a complex neoplastic phenotype by a single oncogenic lesion. Molecular Cell. ,vol. 3, pp. 565- 577 ,(1999) , 10.1016/S1097-2765(00)80350-0
C. Bello-Fernandez, G. Packham, J. L. Cleveland, The ornithine decarboxylase gene is a transcriptional target of c-Myc. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 90, pp. 7804- 7808 ,(1993) , 10.1073/PNAS.90.16.7804
David M. Reese, Dennis J. Slamon, HER-2/neu signal transduction in human breast and ovarian cancer. Stem Cells. ,vol. 15, pp. 1- 8 ,(1997) , 10.1002/STEM.150001
Andreas Höglund, Lisa M. Nilsson, Linus Plym Forshell, Kirsteen H. Maclean, Jonas A. Nilsson, Myc sensitizes p53-deficient cancer cells to the DNA-damaging effects of the DNA methyltransferase inhibitor decitabine. Blood. ,vol. 113, pp. 4281- 4288 ,(2009) , 10.1182/BLOOD-2008-10-183475